Neuronetics, Inc.’s Post

Thank you for sharing…these results go without saying according to the 3 preventive measures in medicine: 1- Primary Prevention: measures taken to avoid disease expression 2- Secondary Prevention: measures taken to decrease the duration of disease 3- Tertiary Prevention: measures taken to decrease the disability cause by a disease POINT BLANK ….if TMS treatments are compared to pharmaceutical treatments, the incidences and prevelances of SIDE EFFECTS will be FEWER for TMS side. The sooner you intervene with any disorder the better outcome. On the downside though, these adolescents may have more years to live thus more probability for recurrence….. as in pharmaceutical treatments https://lnkd.in/gAQEChi5

With nearly 1 in 5 US adolescents experiencing at least one major depressive episode annually, NeuroStar TMS offers a new ray of hope for adolescents like Aubrey. As the first and only FDA-cleared TMS therapy for patients aged 15 and above, NeuroStar is meeting the critical demand for effective treatment of adolescent depression. Data collected through NeuroStar's TrakStar® platform show that 77.8% of adolescents in the analysis saw clinically meaningful improvement. Visit NeuroStar.com to learn how NeuroStar is safely treating depression in adolescents with TMS therapy: https://bit.ly/3T6vxkj #NeuroStar #MentalHealth #AdolescentDepression

🌟 Salience TMS is thrilled to share groundbreaking research from our research team! 🧠 Our latest study is shedding light on how effective Transcranial Magnetic Stimulation (TMS) Therapy is as treatment for adolescent depression and anxiety! 🎉 In our study, we explored the efficacy of TMS in teenagers aged 12–17 diagnosed with major depressive disorder (MDD). And guess what? The results are incredibly promising! 🙌 📈 Here's what we found: - Over half of our participants experienced significant improvements in depression symptoms! - Nearly half achieved remission from anxiety! - And astonishingly, many teens with suicidal thoughts saw them disappear after treatment! 👏 This means hope for teens who haven't found relief with traditional treatments! Plus, it's safe and well-tolerated with no serious side effects reported. 🌟 Our findings underscore the importance of making innovative treatments like TMS therapy accessible to adolescents, just as they are for adults. See the full study in the Brain Stimulation Journal here: https://lnkd.in/g6fTChEy. At Salience, we relentless pursue remission and recovery together, one patient at a time. #TeenMentalHealth #Healthcare #TMSTherapy #EndStigma #Salience #MentalHealth #Depression #Anxiety #Research

DIAGNOSING BIPOLAR DISORDER IS DIFFICULT & COMPLICATED: Here, I briefly address this complexity and offer a few practical, proven tips to improve our diagnostic accuracy. Enjoy!

A study conducted by The Johns Hopkins University School of Medicine explored the impact of naturalistic psychedelic experiences on individuals with Alcohol Use Disorder (AUD). AUD affects nearly 30 million Americans (10.2%). Current treatments often have limited success, highlighting the need for new approaches. For Veterans, this issue is especially critical: 🔹 More than 2 in 10 Veterans with PTSD also have a substance use disorder (SUD) 🔹1 in 10 veterans returning from Iraq or Afghanistan experience alcohol or drug-related issues 🔹According to the National Institute on Drug Abuse, over one-third of military personnel were classified as hazardous drinkers or potentially having an alcohol use disorder 🔹Veterans with AUD are at a significantly higher risk of suicide The study’s participants included individuals with an average of 7 years of problematic alcohol use prior to their psychedelic experience. ➡️After the psychedelic experience, 83% no longer met the criteria for alcohol use disorder (AUD). Participants consistently described their experiences as highly meaningful and insightful. Greater reductions in alcohol use were linked to: 🔹Higher doses of psychedelics 🔹Mystical-type experiences 🔹Profound personal insights 🔹Changes in life priorities or values The researchers concluded that the personal meaning and transformative nature of the psychedelic experience likely play a key role in reducing detrimental behaviors like alcohol misuse. They emphasize that these findings support the need for further research into psychedelic-assisted treatments for alcohol use disorder. We encourage you to share this with your community to help break the stigma, spread awareness, and advocate for solutions that can save lives. 💫 Read more from the study here 🔗https://lnkd.in/gyqPR4pd _____ #psychedelicresearch #psychedelicassistedtherapy #mentalhealth #veteranmentalhealth sources: NIAA: National Survey on Drug Use and Health (NSDUH) 2023 Alcohol use and death by suicide: A meta-analysis of 33 studies (PMID: 35181905) National Center for PTSD Department of Defense Health Related Behaviors Survey (HRBS)

Everyone deserves good mental health. Our technologies support the research and development for new drugs and therapies to improve the quality of life for those experiencing CNS disorders. Download our latest whitepaper to learn how digital biomarkers are used to objectively and practically measure quality of life indicators important to patients with schizophrenia: https://lnkd.in/eYvg9qHm #mentalhealth #CNSdisorders #schizophrenia #digitalbiomarkers

People living with severe mental illness (SMI) face some of the starkest health equality gaps in England, with a life expectancy 15-20 years shorter than that of the general population. This disparity is largely due to preventable physical illnesses. Join Dr Naomi Launders, a Research Fellow in the Division of Psychiatry at University College London, for a webinar on Monday, 23rd September 2024, from 11.00-12.00, titled ‘The Burden of physical long-term conditions in people with severe mental illness: what the medical records tell us.’ The webinar will discuss the burden of physical health conditions in people with SMI and explore ways to improve current practices and interventions to prevent inequalities. Dr Launders will also examine the advantages and challenges of using electronic health records to study themes such as physical health screening in primary care, the timing of physical and mental health diagnoses, and avoidable hospitalisations for physical health among people with SMI. Reserve your spot for free at: https://lnkd.in/epp7WVUW #PCIWEEK24

People living with severe mental illness (SMI) face some of the starkest health equality gaps in England, with a life expectancy 15-20 years shorter than that of the general population. This disparity is largely due to preventable physical illnesses. Join Dr Naomi Launders, a Research Fellow in the Division of Psychiatry at University College London, for a webinar on Monday, 23rd September 2024, from 11.00-12.00, titled ‘The Burden of physical long-term conditions in people with severe mental illness: what the medical records tell us.’ The webinar will discuss the burden of physical health conditions in people with SMI and explore ways to improve current practices and interventions to prevent inequalities. Dr Launders will also examine the advantages and challenges of using electronic health records to study themes such as physical health screening in primary care, the timing of physical and mental health diagnoses, and avoidable hospitalisations for physical health among people with SMI. Reserve your spot via PCI Plus at: https://lnkd.in/e_VMYUju #PCIWEEK24

📣 New Publication Alert: "Talking about borderline personality disorder, shaping care: The multiple doings of narratives". 📑 Read on to delve into the narratives surrounding borderline personality disorder (BPD) within Australian healthcare settings and explore the significant impact these stories can have on care practices and patient experiences. https://lnkd.in/g-TANTAF Key insights from their research include: 🔹 The pervasive stigma and discrimination faced by individuals with a BPD diagnosis. 🔹 The influence of powerful BPD narratives, particularly in acute, short-term, and non-specialist contexts like emergency departments and inpatient units. 🔹 The urgent need to challenge and reframe negative BPD narratives to improve healthcare quality and experiences for those with a BPD diagnosis. Join us in rethinking and reshaping the stories we tell about BPD to foster more compassionate and effective healthcare environments. #research #publication Emma Seal | Tamara Borovica | RMIT Social Equity Research Centre | RMIT University

#Psilocybin shows promise in supporting Premenstrual Dysphoric Disorder And even more things #psilocybin can help with... Need for Clinical Research: Almost all of the women interviewed found their symptoms were reduced after taking psilocybin. This shows great promise as an avenue for research. But, I must mention the selection bias involved in research like this, those women who tried psilocybin and didn’t find it helpful are much less likely to have raised a hand to be interviewed. Importance of Starting Low, Going Slow: Moderate doses were associated with 1 to 3 months of relief from symptoms and an ability to “get on with life”. Women with PMDD are naturally more sensitive and many of the women interviewed shared their challenging experiences. This all supports the idea that starting with low doses and creeping up slowly is much the best approach. Support Required For Self-Experimentation: Many of the women interviewed had ventured into this journey entirely without support, certainly not “psychedelic therapy” as we have come to understand it. This trend of independent, self-experimentation is unlikely to go away. Women often didn’t know exactly how much they had taken. We need guidelines, safety protocols and other materials to support women on their personal journeys in an accessible, low cost way. Bias Towards Prior Experience: Almost everyone interviewed had some prior experience with psychedelics, often as teenagers, thus had enough confidence to use themselves as a guinea-pig. What does that mean for women who have never tried it before? Will they wait decades for psilocybin-based medication to be approved? We are talking about years of impact on their quality of life. Need for Experienced Support for Larger Doses: When combined with deeper integration, preparation, support and personal research, larger doses showed the potential for more transformative effects. Several women found that they had been able to reframe their PMDD as a “gift” – their body’s way of telling them what they needed to work on or change in their lives. This level of transformation is obviously incredibly promising, hopeful and almost unbelievable to women with PMDD, but one must stress that larger doses also present risks. Even though most had experimented alone, every woman interviewed recommended against embarking on this voyage without an experienced guide, and one with experience in PMDD would be ideal. Importance of Community: One common theme that cropped up in the interviews and in the write-up is the importance of community. Feeling seen and heard can be life changing, especially for those with PMDD who often feel isolated and ashamed. For your own experience with legal, safe, private, guided psilocybin experiences, see https://lnkd.in/eJgb7Hk https://lnkd.in/e4sSbgXH